Unico is pursuing consolidation across Latin America, building on flagship operations in Brazil and Mexico as well as a strong client base in other countries throughout the region. The firm outlines its “hypergrowth strategy,” of which the Valida acquisition is an example: “entering a key market by absorbing an already established infrastructure.”
Source: www.biometricupdate.com